Ancala Partners (‘Ancala’), the independent mid-market infrastructure investment manager, has strengthened its infrastructure asset management and investment teams with two new appointments. Ancala has appointed Charles Herriott as Asset Manager to assist in the active management of existing investments in Ancala’s portfolio. He joins from DIF where he was an Asset Manager for a portfolio of 12 PPP and renewable energy assets. He has strong skills in managing infrastructure projects through participating on project company boards and building close relationships with their management teams, co-shareholders and other stakeholders. He has also worked for Amber Infrastructure, Ernst & Young and Smith

Estera, a provider of fiduciary and administration services, has launched in Luxembourg, following its successful acquisition of Headstart earlier this year. Led by managing directors Christophe Gaul and Manuel Mouget, Estera (Luxembourg) provides a full range of high-end specialist corporate and trust services to a diverse client base of private equity and real estate firms, institutional clients and high-net-worth-individuals.   Gaul says: ‘We are proud of the success we have achieved as Headstart and, in order to build on this, it is important that we align ourselves with the Estera brand and values. This exciting step marks the beginning of

Livingbridge has expanded its Equity Funds business with the appointment of David Leahy to Investment Analyst. Leahy initially joined the Livingbridge private equity team in September 2016 to focus on investing in high growth companies, both public and privately owned.  Livingbridge earlier this year expanded the Equity Funds business with the launch of the new CF Livingbridge UK Multi Cap Income Fund, which exists alongside the CF Livingbridge UK Micro Cap Fund, the Livingbridge private equity business and the Baronsmead Venture Trusts.    Leahy’s appointment as Investment Analyst will support the growth of the CF Livingbridge UK Micro Cap Fund and

Partech Ventures has promoted André Francois-Poncet to Principal and appointed Victor Huberson as a Senior Associate, based in Paris. A former M&A banker, André Francois-Poncet, who joined Partech Growth two and a half years ago, helped lead Partech’s investments in Made.com, Brandwatch, EcoVadis, and SendinBlue.   “It has been a real pleasure to see André grow within the Partech Growth team since 2015. His sharp investor flair and a relentless methodical approach to all the opportunities we have analysed and invested in, have impressed the whole Partech partnership. It is only natural to promote him and expand his responsibilities,” says

Bedell Cristin has appointed Lee Osborne as a Senior Associate in its Guernsey office. Osborne (pictured), advises on a broad range of corporate, commercial and banking matters including investment funds and private equity, mergers and acquisitions, joint ventures, cross border transactions and corporate re-structuring.     A member of the BVI Bar Association, Osborne qualified originally as an English lawyer and spent time working at Shoosmiths in London, before moving to the BVI in 2008. In addition to advising on Guernsey law, Osborne also practises BVI law and has previously advised on Cayman Islands law with specific emphasis on open-ended

Prestige has appointed Dr Phil Hobbs as a specialist finance arranger at Privilege Finance, a provider integrated specialist consulting and financial solutions for small businesses within the agricultural, farming and food related sectors across the UK. Hobbs will be focusing on optimising new and under-performing digesters in the agricultural and food waste industries – a core area of funding growth.   Privilege Finance offers a range of funding strategies, including specialist project finance focused on the development of on farm energy, waste to energy and waste to heat related projects within the UK.   Hobbs brings with him considerable experience

Schroders has appointed Reto Schwager as Chief Executive Officer of Schroder Adveq. Schwager joins from the financial services group Orix Corporation where he was Global Head of Private Equity at Robeco and member of the executive committee of Robeco SAM. Prior to that Schwager was a partner and member of the executive board at Partners Group. Before that he was chairman of AIG Investment (Europe).   Schwager will be based in Zurich and report to Stephen Mills, Executive Chairman of Schroder Adveq. He succeeds Sven Liden in the role of CEO and will join the company on 01 January 2018.

Macquarie Capital, the corporate advisory, capital markets and principal investment arm of Macquarie Group, has appointed Matthew Taylor as Head of Business Services, and Henry Elphick as a Senior Consultant to its European business. Taylor will report to Jacques Callaghan, a Senior Managing Director within Macquarie Capital, and Hugh Briggs, Head of Macquarie Capital Europe’s Capital and Principal Solutions Group, which deploys capital to facilitate client transactions. Taylor joins Macquarie from DC Advisory, with more than 10 years’ experience executing complex cross-border transactions in a range of businesses and services. Recent transactions include the acquisition of K2 Partnering Solutions by

Boutique investment bank Invenio Corporate Finance has appointed Chartered Accountant and M&A specialist Matteo Turi as a Partner. Turi has worked in a variety of industries, including renewable energy, utilities, retail banking, telecoms and water services, and has considerable UK and overseas experience.   Turi is an experienced Finance Director and holds several Non-Executive Director roles. He has previously held senior positions within Lanco Solar, Rengen Energy, K2 Partnering and Vanco, and was also part of the senior management at FTSE 100 company Severn Trent Water.   Turi says: “Invenio is growing rapidly in the investment banking sector. I am

Frazier Healthcare Partners has appointed Mark Barrett as an Entrepreneur-in-Residence (EIR) in the firm’s Life Sciences team. Most recently, Barrett served as Global Head of Strategy & Business Development at Sanofi Genzyme and was a member of the company’s executive leadership team responsible for managing Sanofi Genzyme’s global rare diseases, immunology, multiple sclerosis, and oncology businesses. Prior to Genzyme, Barrett held leadership positions in Johnson & Johnson’s business development group and helped launch the Johnson & Johnson Innovation Center in Boston.   “We have known Mark for many years and worked closely with him on the successful spin-out of Incline